0001225208-12-006697.txt : 20120305 0001225208-12-006697.hdr.sgml : 20120305 20120305184114 ACCESSION NUMBER: 0001225208-12-006697 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120301 FILED AS OF DATE: 20120305 DATE AS OF CHANGE: 20120305 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BARD C R INC /NJ/ CENTRAL INDEX KEY: 0000009892 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 221454160 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 730 CENTRAL AVE CITY: MURRAY HILL STATE: NJ ZIP: 07974 BUSINESS PHONE: 9082778000 MAIL ADDRESS: STREET 1: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WEILAND JOHN H CENTRAL INDEX KEY: 0001204663 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06926 FILM NUMBER: 12668152 MAIL ADDRESS: STREET 1: C/O C.R BARD INC STREET 2: 730 CENTRAL AVE CITY: MURRAY HILL STATE: NJ ZIP: 07974 4 1 doc4.xml X0304 4 2012-03-01 0000009892 BARD C R INC /NJ/ BCR 0001204663 WEILAND JOHN H C/O C. R. BARD, INC. 730 CENTRAL AVENUE MURRAY HILL NJ 07974 1 1 President and COO Common Stock 2012-03-05 4 S 0 8789.0000 92.9143 D 186910.2900 D Common Stock 5238.5100 I 401(k) Plan Restricted Stock Units 2012-03-01 4 A 0 12111.0000 0.0000 A Common Stock 12111.0000 12111.0000 D Sales are pursuant to a previously disclosed 10b5-1 plan. Represents the weighted average sales price for price increments ranging from $92.67 to $93.30. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. These restricted stock units were granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated) and will be settled in common stock upon the Compensation Committee's certification of performance achievement following the completion of the performance period ending on December 31, 2014. The amount of shares reported represents the payout at target performance level, however, the reporting person will earn between 0% and 200% of target based upon the Company's performance over the performance period. Myra McGinley, Attorney-in-Fact 2012-03-05